Log in
Enquire now
‌

US Patent 11883475 Infectious

Patent 11883475 was granted and assigned to Sanaria Inc. on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Sanaria Inc.
Sanaria Inc.
0
Current Assignee
Sanaria Inc.
Sanaria Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118834750
Patent Inventor Names
Abraham G. Eappen0
Stephen L Hoffman0
Date of Patent
January 30, 2024
0
Patent Application Number
175298120
Date Filed
November 18, 2021
0
Patent Citations
‌
US Patent 8821896 Purified
0
‌
US Patent 8992944 Purified
0
‌
US Patent 9241982 Purified plasmodium and vaccine compositions
0
‌
US Patent 9278125 Pharmaceutical compositions comprising attenuated
0
‌
US Patent 9616115 Purified plasmodium and vaccine compositions
0
‌
US Patent 9642909 Pharmaceutical compositions comprising attenuated
0
‌
US Patent 9764016 Genetic attenuation of
0
‌
US Patent 9878026 Infectious plasmodium sporozoites grown in vitro
0
...
Patent Primary Examiner
‌
Jennifer E. Graser
0
Patent abstract

The application is directed to in vitro-reared

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11883475 Infectious

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.